Triple negative breast cancer (TNBC), defined as the absence of both hormone receptor expression and erb-B2 receptor tyrosine kinase 2 (ERBB2) overexpression, accounts for approximately 15-20 % of all breast cancers [1]. Here, NR4A1 is linked to breast cancer.